Crocin, the main active saffron constituent, as an adjunctive treatment in major depressive disorder: A randomized, double-blind, placebo-controlled, pilot clinical trial

Depressive Disorder ◽

Adjunctive Treatment ◽

Major Depressive ◽

Double Blind ◽

Effect of prebiotic and probiotic supplementation on circulating pro-inflammatory cytokines and urinary cortisol levels in patients with major depressive disorder: A double-blind, placebo-controlled randomized clinical trial

Journal of Functional Foods ◽

10.1016/j.jff.2018.11.041 ◽

2019 ◽

Vol 52 ◽

pp. 596-602 ◽

Cited By ~ 9

Author(s):

Asma Kazemi ◽

Ahmad Ali Noorbala ◽

Kamal Azam ◽

Kurosh Djafarian

Keyword(s):

Clinical Trial ◽

Depressive Disorder ◽

Inflammatory Cytokines ◽

Urinary Cortisol ◽

Major Depressive ◽

Probiotic Supplementation ◽

Double Blind ◽

Double Blind Placebo ◽

Pro Inflammatory Cytokines

A double-blind, placebo-controlled study of edivoxetine as an adjunctive treatment for patients with major depressive disorder who are partial responders to selective serotonin reuptake inhibitor treatment

Journal of Affective Disorders ◽

10.1016/j.jad.2014.06.006 ◽

2014 ◽

Vol 167 ◽

pp. 215-223 ◽

Cited By ~ 9

Author(s):

Susan Ball ◽

Mary Anne Dellva ◽

Deborah N. D'Souza ◽

Lauren B. Marangell ◽

James M. Russell ◽

...

Keyword(s):

Depressive Disorder ◽

Selective Serotonin Reuptake Inhibitor ◽

Serotonin Reuptake ◽

Adjunctive Treatment ◽

Controlled Study ◽

Major Depressive ◽

Double Blind ◽

Double Blind Placebo ◽

Inhibitor Treatment

Antidepressants effects of Rhodiola capsule combined with sertraline for major depressive disorder: A randomized double-blind placebo-controlled clinical trial

Journal of Affective Disorders ◽

10.1016/j.jad.2020.01.065 ◽

2020 ◽

Vol 265 ◽

pp. 99-103

Author(s):

Lili Gao ◽

Chenghan Wu ◽

Yuansheng Liao ◽

Jinmin Wang

Keyword(s):

Clinical Trial ◽

Depressive Disorder ◽

Major Depressive ◽

Double Blind ◽

Efficacy and safety of TS-121, a novel vasopressin V1B receptor antagonist, as adjunctive treatment for patients with major depressive disorder: A randomized, double-blind, placebo-controlled study

Journal of Psychiatric Research ◽

10.1016/j.jpsychires.2020.05.017 ◽

2020 ◽

Vol 128 ◽

pp. 43-51

Author(s):

Makoto Kamiya ◽

Helene D. Sabia ◽

Julie Marella ◽

Maurizio Fava ◽

Charles B. Nemeroff ◽

...

Keyword(s):

Depressive Disorder ◽

Receptor Antagonist ◽

Adjunctive Treatment ◽

Controlled Study ◽

Efficacy And Safety ◽

Major Depressive ◽

Double Blind ◽

Double Blind Placebo ◽

V1b Receptor

Efficacy and safety of pentoxifylline combination therapy in major depressive disorder: a randomized, double-blind, placebo-controlled clinical trial

International Clinical Psychopharmacology ◽

10.1097/yic.0000000000000353 ◽

2021 ◽

Vol 36 (3) ◽

pp. 140-146

Author(s):

Mostafa Farajollahi-Moghadam ◽

Hossein Sanjari-Moghaddam ◽

Maryam Ghazizadeh Hasemi ◽

Zahra Sanatian ◽

Ali Talaei ◽

...

Keyword(s):

Clinical Trial ◽

Combination Therapy ◽

Depressive Disorder ◽

Efficacy And Safety ◽

Major Depressive ◽

Double Blind ◽

Topiramate augmentation in patients with resistant major depressive disorder: A double-blind placebo-controlled clinical trial

Progress in Neuro-Psychopharmacology and Biological Psychiatry ◽

10.1016/j.pnpbp.2011.01.016 ◽

2011 ◽

Vol 35 (4) ◽

pp. 970-973 ◽

Cited By ~ 12

Author(s):

Arash Mowla ◽

Ehsan Kardeh

Keyword(s):

Clinical Trial ◽

Depressive Disorder ◽

Major Depressive ◽

Double Blind ◽

Efficacy and safety of tipepidine as adjunctive therapy in major depressive disorder: A randomized, double‐blind, placebo‐controlled clinical trial

Psychiatry and Clinical Neurosciences ◽

10.1111/pcn.13180 ◽

2020 ◽

Author(s):

Saba Hoobehfekr ◽

Hossein Sanjari Moghaddam ◽

Mohammadreza Shalbafan ◽

Maryam Ghazizadeh Hashemi ◽

Mohammad Mehdi Pirmoradi ◽

...

Keyword(s):

Clinical Trial ◽

Depressive Disorder ◽

Adjunctive Therapy ◽

Efficacy And Safety ◽

Major Depressive ◽

Double Blind ◽

S102. Pilot Double-Blind, Placebo-Controlled Clinical Trial of Transcranial Alternating Current Stimulation (tACS) for the Treatment of Major Depressive Disorder

Biological Psychiatry ◽

10.1016/j.biopsych.2018.02.993 ◽

2018 ◽

Vol 83 (9) ◽

pp. S386-S387 ◽

Cited By ~ 2

Author(s):

Morgan Alexander ◽

Sankaraleengam Alagapan ◽

Courtney Lugo ◽

Juliann Mellin ◽

Caroline Lustenberger ◽

...

Keyword(s):

Clinical Trial ◽

Depressive Disorder ◽

Alternating Current ◽

Transcranial Alternating Current Stimulation

Major Depressive ◽

Double Blind ◽

Double Blind Placebo ◽

AUGMENTATION OF FLUOXETINE WITH LOVASTATIN FOR TREATING MAJOR DEPRESSIVE DISORDER, A RANDOMIZED DOUBLE-BLIND PLACEBO CONTROLLED-CLINICAL TRIAL

Depression and Anxiety ◽

10.1002/da.22195 ◽

2013 ◽

Vol 30 (11) ◽

pp. 1084-1088 ◽

Cited By ~ 37

Author(s):

Ahmad Ghanizadeh ◽

Arvin Hedayati

Keyword(s):

Clinical Trial ◽

Depressive Disorder ◽

Major Depressive ◽

Double Blind ◽

Faculty Opinions recommendation of Omega-3 fatty acids for major depressive disorder during pregnancy: results from a randomized, double-blind, placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1103835.559964 ◽

2008 ◽

Author(s):

Deborah Kim

Keyword(s):

Fatty Acids ◽

Depressive Disorder ◽

Controlled Trial ◽

Omega 3 Fatty Acids ◽

Omega 3 ◽

Major Depressive ◽

Double Blind ◽